Unknown

Dataset Information

0

Spray-dried nanocrystal-loaded polymer microparticles for long-term release local therapies: an opportunity for poorly soluble drugs.


ABSTRACT: Nano- and micro-technologies can salvage drugs with very low solubility that were doomed to pre-clinical and clinical failure. A unique design approach to develop drug nanocrystals (NCs) loaded in extended release polymeric microparticles (MPs) for local treatments is presented here through the case of a potential osteoarthritis (OA) drug candidate for intra-articular (IA) administration. Optimizing a low-shear wet milling process allowed the production of NCs that can be subsequently freeze-dried (FD) and redispersed in a hydrophobic polymer-organic solvent solution to form spray-dried MPs. Results demonstrated a successful development of a ready-to-upscale formulation containing PLGA MPs with high drug NC encapsulation rates that showed a continuous and controlled drug release profile over four months. The screenings and procedures described allowed for identifying and overcoming common difficulties and challenges raised along the drug reduction to nano-size and spray-drying process. Above all, the technical knowledge acquired is intended for formulation scientists aiming to improve the therapeutic perspectives of poorly soluble drugs.

SUBMITTER: Rodriguez-Nogales C 

PROVIDER: S-EPMC10987046 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Spray-dried nanocrystal-loaded polymer microparticles for long-term release local therapies: an opportunity for poorly soluble drugs.

Rodríguez-Nogales Carlos C   Meeus Joke J   Thonus Gaby G   Corveleyn Sam S   Allémann Eric E   Jordan Olivier O  

Drug delivery 20231122 1


Nano- and micro-technologies can salvage drugs with very low solubility that were doomed to pre-clinical and clinical failure. A unique design approach to develop drug nanocrystals (NCs) loaded in extended release polymeric microparticles (MPs) for local treatments is presented here through the case of a potential osteoarthritis (OA) drug candidate for intra-articular (IA) administration. Optimizing a low-shear wet milling process allowed the production of NCs that can be subsequently freeze-dri  ...[more]

Similar Datasets

| S-EPMC11661805 | biostudies-literature
| S-EPMC8236044 | biostudies-literature
| S-EPMC6047912 | biostudies-literature
| S-EPMC9822401 | biostudies-literature
| PRJNA1039989 | ENA
| S-EPMC11474811 | biostudies-literature
| S-EPMC6092326 | biostudies-literature
| S-EPMC6912732 | biostudies-literature
| S-EPMC6475500 | biostudies-literature